% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Amundarain:861857,
author = {Amundarain, María Julia and Viso, Juan Francisco and
Zamarreño, Fernando and Giorgetti, Alejandro and Costabel,
Marcelo},
title = {{O}rthosteric and benzodiazepine cavities of the α 1 β 2
γ 2 {GABA} {A} receptor: insights from experimentally
validated in silico methods},
journal = {Journal of biomolecular structure $\&$ dynamics},
volume = {37},
number = {6},
issn = {0739-1102},
address = {Abingdon [u.a.]},
publisher = {Taylor $\&$ Francis},
reportid = {FZJ-2019-02278},
pages = {1597 - 1615},
year = {2019},
abstract = {γ-aminobutyric acid-type A (GABAA) receptors mediate fast
synaptic inhibition in the central nervous system of
mammals. They are modulated via several sites by numerous
compounds, which include GABA, benzodiazepines, ethanol,
neurosteroids and anaesthetics among others. Due to their
potential as targets of novel drugs, a detailed knowledge of
their structure-function relationships is needed. Here, we
present the model of the α1β2γ2 subtype GABAA receptor in
the APO state and in complex with selected ligands,
including agonists, antagonists and allosteric modulators.
The model is based on the crystallographic structure of the
human β3 homopentamer GABAA receptor. The complexes were
refined using atomistic molecular dynamics simulations. This
allowed a broad description of the binding modes and the
detection of important interactions in agreement with
experimental information. From the best of our knowledge,
this is the only model of the α1β2γ2 GABAA receptor that
represents altogether the desensitized state of the channel
and comprehensively describes the interactions of ligands of
the orthosteric and benzodiazepines binding sites in
agreement with the available experimental data. Furthermore,
it is able to explain small differences regarding the
binding of a variety of chemically divergent ligands.
Finally, this new model may pave the way for the design of
focused experimental studies that will allow a deeper
description of the receptor.},
cin = {IAS-5 / INM-9},
ddc = {570},
cid = {I:(DE-Juel1)IAS-5-20120330 / I:(DE-Juel1)INM-9-20140121},
pnm = {574 - Theory, modelling and simulation (POF3-574)},
pid = {G:(DE-HGF)POF3-574},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29633901},
UT = {WOS:000461434300018},
doi = {10.1080/07391102.2018.1462733},
url = {https://juser.fz-juelich.de/record/861857},
}